| Transaction Date | Recipient | Shares | Type | Price | Value |
|---|---|---|---|---|---|
| 25th November 2020 | Christopher Bischoff | 713 | Exercise of derivative | $0.00 | |
| 25th November 2020 | Sandra L Fenwick | 7,173 | Exercise of derivative | $0.00 | |
| 25th November 2020 | Karen L Daniel | 7,173 | Exercise of derivative | $0.00 | |
| 30th October 2020 | Hemant Taneja | 7,922 | Other acquisition or disposition | $0.00 | |
| 30th October 2020 | Hemant Taneja | 982,160 | Disposition due to a tender of shares in a change of control transaction | $0.00 | |
| 30th October 2020 | Hemant Taneja | 13,943,216 | Disposition due to a tender of shares in a change of control transaction | $0.00 | |
| 30th October 2020 | Catalyst Group Management Holdings Gp, Llc General | 982,160 | Disposition due to a tender of shares in a change of control transaction | $0.00 | |
| 30th October 2020 | Catalyst Group Management Holdings Gp, Llc General | 7,922 | Other acquisition or disposition | $0.00 | |
| 30th October 2020 | Hemant Taneja | 14,048 | Disposition due to a tender of shares in a change of control transaction | $0.00 | |
| 30th October 2020 | Catalyst Group Management Holdings Gp, Llc General | 2,892,681 | Disposition due to a tender of shares in a change of control transaction | $0.00 |
Livongo Health
Based on disclosure changes, sentiment, insider trading and news impact we give a rating of 6/10.
Livongo Health, Inc. develops and operates a consumer digital health platform. It focuses on diabetes, hypertension, weight management, diabetes prevention, and behavioral health. The company was founded by Kimon Angelides and Glen E. Tullman on October 16, 2008.
Ticker: LVGO
Sector: Technology Services
Industry: Packaged Software
SEC Central Index Key (CIK): 1639225
Employees: 615
Exchange: NASDAQ
Auditor Opinion:
You must Login to see Language Changes
Disclosure Language changes
You must Login to see analysis
Red Flags
Increase Decrease In Due To Related Parties of $0 for the period Jan 2020 to Jun 2020 in the context of all up
Increase Decrease In Due To Related Parties of $2 M for the period Jan 2019 to Jun 2019 in the context of all up
Fundamentals
Cash at Carrying Value: $686 M (0%)
Inventory, Net: $18 M (-39%)
Other Assets, Current: $0 (-100%)
Assets, Current: $951 M (95%)
Property, Plant and Equipment, Net: $16 M (0%)
Other Assets, Noncurrent: $569 Th (0%)
Assets: $1 B (87%)
Accounts Payable, Current: $6 M (-23%)
Accrued Liabilities, Current: $36 M (0%)
Liabilities, Current: $48 M (14%)
Other Liabilities, Noncurrent: $397 Th (-86%)
Liabilities: $471 M (785%)
Common Stock, Value, Issued: $100 Th (5%)
Retained Earnings (Accumulated Deficit): $171 M (0%)
Stockholders' Equity (Parent): $578 M (0%)
Liabilities and Equity: $1 B (87%)
Revenue: $92 M (-42%)
Cost of Revenue: $21 M (-45%)
Gross Margin: $70 M (-41%)
Research and Development: $16 M (-46%)
Sales and Marketing: $33 M (-45%)
General and Administrative Expenses: $22 M (-41%)
Operating Income/Loss: $262 Th (-96%)
Provision for income taxes: $72 Th (-22%)
News
Top Buys From The Best Money Managers (Q3 2020)
18th November 2020
Teladoc Health - Be Patient, This Investment Will Work Out
18th November 2020
Teladoc Is A Strong Buy: A Radical Healthcare Change Will Come
10th November 2020
DXP Enterprises Reports Third Quarter 2020 Results
6th November 2020